Biggest News Aggregation in the World
📰 Erin Mauney News

Erin Mauney News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Erin Mauney. Real-time updates on events, politics, business and more.

Tryp Therapeutics Receives Confirmation From FDA To Proceed With Phase 2A Clinical Trial in Patients With IBS at Massachusetts General Hospital - Tryp Therapeutics (OTC:TRYPF)

KELOWNA, BC / ACCESSWIRE / July 13, 2023 / Tryp Therapeutics, Inc. (CSE:TRYP)(OTCQB:TRYPF) ("Tryp" or the "Company"), a clinical-stage biotechnology company focused on developing intravenous-infused
United States Peter Molloy Erin Mauney Jim Gilligan University Of Michigan Tryp Therapeutics Inc

Psilocybin For IBS Gets FDA Nod To Begin Clinical Trials At Mass. General Hospital - Tryp Therapeutics (OTC:TRYPF)

Tryp Therapeutics’ (OTCQB: TRYPF) latest Investigational New Drug (IND) application was approved by the FDA, enabling the company to begin Phase 2a clinical trials at the Massachusetts General Hospital (MGH) on the effects of psilocybin-assisted psychotherapy for adults with Irritable B
United States Jim Gilligan Erin Mauney University Of Florida University Of Michigan Harvard Medical School

Tryp Therapeutics Completes Psychotherapy Training for Planned Phase 2a Clinical Trial at Massachusetts General Hospital

KELOWNA, BC / ACCESSWIRE / April 4, 2023 / Tryp Therapeutics, Inc. (CSE:TRYP)(OTCQB:TRYPF) ("Tryp" or the "Company"), a clinical-stage biotechnology company focused on developing intravenous-infused psilocin
United States Elizabeth Nielson Erin Mauney Jim Gilligan Peter Molloy University Of Michigan

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science